ArticleInternational journal of hematology2009

A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma: beta2-microglobulin associated with time to progression.

Hiroto Ohguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.